The efficacy and tolerance of Arthron® triactive forte drug preparation (manufactured by Unipharm Inc., USA) in the system of treatment of joint injuries in sportsmen

Authors

  • Volodymyr Radchenko
  • Natalya Bolkhovitina
  • Pavlo Bolkhovitin

DOI:

https://doi.org/10.15674/0030-59872009473-78

Keywords:

sport, trauma, joint, chondroitin sulfate, glucosamine hydrochloride, MSM

Abstract

The efficacy and tolerance of Arthron® triactive forte (manufactured by Unipharm Inc., USA) as the basic drug preparation for treating traumatic pathology of joints in sportsmen were studied. The obtained results demonstrate a good tolerance and efficacy of the drug in sports traumatology.

References

  1. Клиническая фармакология и фармакотерапия в ревматологии / П.А. Ангелуца, А.П. Викторов, В.Н. Коваленко. — К., 1995. — 504 с.
  2. Бадокин В.В. Современная терапия остеоартроза / В.В. Бадокин: изд-во «Открытые Системы» (www.osp.ru). — Лечащий врач. — 2001. — № 8.
  3. Дзяк Г.В. Нестероидные противовоспалительные препараты / Г.В. Дзяк. — К.: Морион, 1999. — 111 с.
  4. Клинические испытания лекарств: под ред. В.И. Мальцева, Т.К. Ефимцевой, Ф.Б. Белоусова, В.Н. Коваленко. — Киев, 2002. — 350 с.
  5. Компендиум 2007 — лекарственные препараты в двух томах: под ред. В.Н. Коваленко, А.П. Викторова. — К.: МОРИОН, 2007. — 2270 с.
  6. Altman R.D. / R.D. Altman, C.J. Lozada // Osteoarth. Caitil. — 1998. — Vol. 5. — P. 22–24.
  7. Brooks P. / P. Brooks // Ann.Rheum.Dis. — 2001. — № 60 (Suppl. 1) — P. 33–47.
  8. Eular Recommendations 2003: An Evidence Based Approach to the Management of Knee Osteoarthritis / K.M. Jordan, N.K. Arden, M. Doherty et al. — Report of a Task Force Committee for Proprietary Medicinal Products, July 1998.
  9. The American College of Rheumatology 1990 criteria for the classification of Charg-Strauss syndrome / A.T. Masi, G.G. Hunder, J.T. Lie et al. //Arthritis Rheum. — 1990. — Vol. 33. — P. 1094–1100.
  10. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases / P. Patrignani, M.R. Panara, A. Greco et al. // J.Pharmacol. Exp Ther. — 1994. — Vol. 271. — P. 1705–1710.
  11. Inhibition of prostaglandinsynthesis as a mechanism of action for aspirine-like drug / J.R. Vane // Nature [New Biology]. — 1971. — Vol. 273. — P. 272–235.

Downloads

How to Cite

Radchenko, V., Bolkhovitina, N., & Bolkhovitin, P. (2009). The efficacy and tolerance of Arthron® triactive forte drug preparation (manufactured by Unipharm Inc., USA) in the system of treatment of joint injuries in sportsmen. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (4), 73–78. https://doi.org/10.15674/0030-59872009473-78

Issue

No. 4 (2009)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2014 Volodymyr Radchenko, Natalya Bolkhovitina, Pavlo Bolkhovitin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).